Explore the evolving landscape of diabetes care focusing on physical, mental, and emotional health. Discover innovative practices that enhance overall well-being, including mindfulness and nutrition, ...

In Uganda, especially in rural Uganda and the elderly populace, the diabetes epidemic presents daunting hurdles ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for GLP-1 drugs could likely be a lot bigger. Based on data ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

This is excellent news! Dr. Saladino (@paulsaladinomd2) explains that prescription weight loss medications like Ozempic work ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Young adults with type 2 diabetes and lower incomes face significantly higher mortality risks, highlighting socioeconomic ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Kidney disease is a leading cause of death in America, killing more people than breast cancer or prostate cancer.